Albireo Pharma Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2022 to a ratio of 27.25, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the third quarter 2022. Average receivable collection period, for the Albireo Pharma Inc in Sep 30 2022 quarter, has decreased to 13 days, compared to 14 days, in the Jun 30 2022 quarter.

If we take a look into Healthcare sector 448 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. 3039.

What is Receivable Turnover Ratio?
What is Albireo Pharma Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ALBO Receivables Turnover Ratio	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter	(Sep 30 2021) III. Quarter
Y / Y Receivable Change	55.24 %	-	-	-	-
Y / Y Revenue Change	168.34 %	237.97 %	247.51 %	1097.39 %	71.94 %
Receivable Turnover Ratio (TTM)	27.25	26.6	31.05	35.45	32.97
ALBO's Total Ranking	# 3039	# 3039	# 508	# 508	# 2253
Accounts Receivable average collection period days	13	14	12	10	11
Seq. Receivable Change	9.73 %	45.02 %	-61.03 %	150.34 %	-
Seq. Revenue Change	19.81 %	20.11 %	-78.99 %	787.58 %	50.91 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 150
Healthcare Sector	# 449
Overall Market	# 3039

Receivable Turnover Ratio Statistics
High	Average	Low
0.21	0.08	0.01
(Sep 30 2022)		(Mar 31 2019)

ALBO Company Profile • Back to ALBO Efficiency Comparisons • Compare ALBO Receivables Turnover Ratio to its Competitors

Financial Statements
Albireo Pharma Inc 's Accounts Receivable	$ 2 Millions	Visit ALBO's Balance sheet
Albireo Pharma Inc 's Sales TTM	$ 57 Millions	Visit ALBO's Income Statement
Sources of ALBO's Revenues		Visit ALBO's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ALBO's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ALBO's Growth Rates	ALBO's Roa	ALBO's Inventory Turnover Ratio	ALBO's Dividend Comparisons
ALBO's Profitability Ratios	ALBO's Roi	ALBO's Asset Turnover Ratio	ALBO's Dividend Growth
ALBO's Valuation Ratios	ALBO's Roe	ALBO's Financial Strength Ratios	ALBO's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2022, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2022	Receivable at quarter ending Sep 30 2022
Zeo Scientifix Inc	73.92	$ 6.491 Millions	$ 0.088 Millions
Arrowhead Pharmaceuticals Inc	73.59	$ 243.231 Millions	$ 3.305 Millions
Cytomx Therapeutics Inc	63.50	$ 71.943 Millions	$ 1.133 Millions
Invo Fertility Inc	60.63	$ 3.592 Millions	$ 0.059 Millions
Lifemd Inc	59.65	$ 116.730 Millions	$ 1.957 Millions
Janux Therapeutics Inc	59.06	$ 7.383 Millions	$ 0.125 Millions
Iterum Therapeutics Plc	58.69	$ 6.060 Millions	$ 0.103 Millions
Lifevantage Corp	56.25	$ 204.910 Millions	$ 3.643 Millions
Brookdale Senior Living Inc	53.83	$ 2,720.961 Millions	$ 50.545 Millions
Logicmark Inc	53.73	$ 12.188 Millions	$ 0.227 Millions
Sonida Senior Living Inc	52.51	$ 236.512 Millions	$ 4.504 Millions
Essa Pharma inc	51.19	$ 0.601 Millions	$ 0.012 Millions
Morphic Holding inc	49.13	$ 74.230 Millions	$ 1.511 Millions
Nature s Sunshine Products inc	47.69	$ 437.100 Millions	$ 9.165 Millions
Agape Atp Corporation	47.08	$ 1.680 Millions	$ 0.036 Millions
Editas Medicine Inc	41.51	$ 25.644 Millions	$ 0.618 Millions
Histogen Inc	38.27	$ 3.770 Millions	$ 0.099 Millions
Aclaris Therapeutics Inc	37.75	$ 23.500 Millions	$ 0.623 Millions
Ideaya Biosciences Inc	36.03	$ 49.871 Millions	$ 1.384 Millions
National Vision Holdings Inc	32.81	$ 2,014.324 Millions	$ 61.385 Millions
Tvardi Therapeutics Inc	31.20	$ 39.427 Millions	$ 1.264 Millions
Electromedical Technologies Inc	31.17	$ 0.963 Millions	$ 0.031 Millions
Notable Labs Ltd	30.83	$ 1.426 Millions	$ 0.046 Millions
Sqz Biotechnologies Company	29.18	$ 21.886 Millions	$ 0.750 Millions
Voyager Therapeutics Inc	28.21	$ 70.531 Millions	$ 2.500 Millions
Albireo Pharma inc	27.25	$ 57.391 Millions	$ 2.106 Millions
Arbutus Biopharma Corp	26.09	$ 35.980 Millions	$ 1.379 Millions
Vireo Growth Inc.	25.49	$ 69.239 Millions	$ 2.717 Millions
Immunogen inc	25.22	$ 95.607 Millions	$ 3.792 Millions
Inmed Pharmaceuticals Inc	25.18	$ 1.410 Millions	$ 0.056 Millions

Date modified: 2026-08-29T17:15:10+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.